China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Xi chairs meeting on ideological work, draft ethnic unity law
- Cave basketball in Southwest China's Guizhou goes into limelight
- Global allies' contributions to China's resistance recognized at symposium
- Egyptians laud TCM veterinary summer program
- New war memorials honor sacrifices home, abroad
- Closer ties highlighted for regional energy security
